/Investor DB

ALTITUDE LIFE SCIENCE VENTURES

Venture capital

Kirkland · 1 people tracked

Find your way into ALTITUDE LIFE SCIENCE VENTURES

1 people in our graph share verified history with the ALTITUDE LIFE SCIENCE VENTURES team — schools, employers, funds. One of them is your warm intro.

✨ Fox Verdict
Sign up to see your fit

Fund manager profile

ALTITUDE LIFE SCIENCE VENTURES is a venture fund manager based in Kirkland. SEC filings show 5 venture funds on record, most recently Altitude Life Science Ventures Fund IV, L.P. ($150M offering) filed October 2020.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

What founders say

No founder feedback on ALTITUDE LIFE SCIENCE VENTURES yet.

HQ
Kirkland, US
Founded
2015
Tracked investments
10
Unicorns
3
IPOs
4
Acquisitions
3

Team · 1 people

from public directories
David J. Maki· General Partner

What they invest in

from 9 of 10 portfolio companies

Biotech ×9Deep Tech ×4Medical Devices ×4AI & Machine Learning ×3Digital Health ×2Healthtech ×1

HQs:United States×8

Investments · 10 tracked

founders shown can be your intro path

By year:2023 · 12022 · 12021 · 12020 · 12019 · 12018 · 22015 · 18 dated

Generate Biomedicinesgeneratebiomedicines.comin𝕏NASDAQ: GENBNov 2021 · $370M

Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.

AI & Machine LearningBiotechDeep TechSomerville, US

Gevorg Grigoryan(Co-Founder & Chief Technology Officer)inMichael Nally(Chief Executive Officer)in

Co-investorsFlagship PioneeringARCH Venture PartnersMarch Capital PartnersAlaska Permanent Fund CorporationAmgen VenturesNVentures+1 more

Neumora Therapeuticsneumoratx.comin𝕏NASDAQ: NMRAOct 2022 · $112M

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+10 more

Pulmatrixpulmatrix.comNASDAQ: PULMJun 2015 · $10M

Pulmatrix develops inhaled dry-powder therapies using its proprietary iSPERSE technology, which uses small, dense, dispersible particles to deliver respiratory and non-respiratory drugs via the respiratory system.

BiotechDeep TechHealthtechMedical DevicesFramingham, US

Anand Varadan(Director)inRichard Batycky(Director)Peter Ludlum(Interim Chief Executive Officer)Hojabr Alimi(Executive Officer)Sameer Harish(Executive Officer)

BoardRichard Conley(Director)

Co-investors5AM VenturesARCH Venture PartnersPolaris Partners

Virvir.bioin𝕏NASDAQ: VIRMay 2020

Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities.

AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US

Marianne De Backer(CEO)inHerbert Virgin(Executive Officer)Howard Horn(Executive Officer)inAlex Bangs(Executive Officer)inMarianne De Backer, M.Sc., Ph.D., MBA(President, Chief Executive Officer and Director)

BoardGeorge Scangos(Executive Officer, Director)

Co-investorsAlta PartnersARCH Venture PartnersGV (Google Ventures)SoftBank Vision Fund8VCSoftBank Group

Kythera Biopharmaceuticalsallergan.comAcquired

Aesthetic-medicine biopharma behind KYBELLA (deoxycholic acid) injection, acquired by Allergan in 2015 for ~$2.1 billion.

Co-investorsAisling CapitalARCH Venture PartnersMESA VERDE VENTURE PARTNERSProspect Venture PartnersSchooner CapitalFoley Ventures+1 more

Mozart Therapeuticsmozart-tx.comJun 2023 · $25M

Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.

BiotechMedical Devices

Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)in

Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+4 more

Omniomeomniome.comJul 2018Acquired

San Diego DNA sequencing company behind the Sequencing by Binding short-read platform; acquired by Pacific Biosciences in 2021.

BiotechSan Diego, US

David S. Mullarkey(Executive Officer, Director)Arnold Oliphant(Executive Officer)inKen Song, M.D., Ph.D.(Executive Officer, Director)Kelly Perez(Executive Officer)John Murphy, Ph.D.(Executive Officer)Millard Y Chan(Chief Operating Officer, Secretary and Director)

Co-investorsARCH Venture PartnersATEL VenturesDCVC (Data Collective)Decheng CapitalLam CapitalPivotal Life Sciences+3 more

Thumbnail for Escient Pharmaceuticalsescientpharma.com

BiotechSan Diego, US

Alain Baron(Executive Officer, Director)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Executive Officer)

BoardAndrew Schwab(Director)in

Co-investors5AM VenturesAvego BioScience CapitalNew Enterprise Associates (NEA)OUP (Osage University Partners)Sanofi VenturesThe Column Group+3 more

Unity Biotechnologyunitybiotechnology.cominMar 2018Defunct

Unity Biotechnology was a biotechnology company that is no longer operating.

BiotechBrisbane, US

Nathaniel E. David(Executive Officer, Director)inDan Marquess(Executive Officer)inKeith Leonard(Executive Officer, Director)inTamara Tompkins(Executive Officer)inBob Goeltz(Executive Officer)inJamie Dananberg(Executive Officer)in

Co-investorsage1ARCH Venture PartnersCycad Group LLCEcoR1 CapitalKhosla VenturesVenrock+5 more

Vividion Therapeuticsvividion.cominApr 2019 · $82Macquired by Bayer

Vividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins.

AI & Machine LearningBiotechDeep TechPrinceton, US

Ben Cravatt(Scientific Founder)Phil Baran(Scientific Founder)Jin-Quan Yu(Scientific Founder)Aleksandra Rizo(President and Chief Executive Officer)in

BoardJohn Park(Executive Officer)John Clarke(Executive Officer, Director)in

Co-investorsARCH Venture PartnersAvoro Capital AdvisorsCardinal PartnersNextech InvestSoftBank Vision FundAlexandria+4 more

Exits · 7

4 IPOs · 3 acquisitions · showing 5

Generate BiomedicinesNASDAQ: GENBNeumora TherapeuticsNASDAQ: NMRAPulmatrixNASDAQ: PULMVirNASDAQ: VIRVividion Therapeuticsacq. by Bayer

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has ALTITUDE LIFE SCIENCE VENTURES made?
ALTITUDE LIFE SCIENCE VENTURES has 10 tracked investments, 7 of which have exited.
Where is ALTITUDE LIFE SCIENCE VENTURES located?
ALTITUDE LIFE SCIENCE VENTURES is headquartered in Kirkland, US.

Featured in lists